Pacira BioSciences (PCRX) Market Capitalization (2011 - 2026)

Pacira BioSciences has reported Market Capitalization for 16 years, with the latest figure at $1.0 billion in Q2 2026.

• On a quarterly basis, Market Capitalization fell 5.85% year-over-year to $1.0 billion in Q2 2026; TTM through Jun 2026 was $1.0 billion, a 5.85% decrease from a year earlier, with the FY2025 full-year figure at $1.1 billion, up 22.15% from the prior year.
• Market Capitalization was $1.0 billion for Q2 2026 at Pacira BioSciences, up from $888.4 million in the prior quarter.
• The five-year high for Market Capitalization was $3.4 billion in Q1 2022, with the low at $694.5 million in Q3 2024.
• Average Market Capitalization over 5 years is $1.5 billion, with a median of $1.3 billion recorded in 2024.
• The sharpest annual moves came in 2024 and 2025: Market Capitalization sank 51.24% in 2024, then surged 59.42% in 2025.
• Over 5 years, Market Capitalization stood at $1.8 billion in 2022, then fell by 11.56% to $1.6 billion in 2023, then plunged by 44.45% to $871.2 million in 2024, then climbed by 22.15% to $1.1 billion in 2025, then fell by 5.06% to $1.0 billion in 2026.
• The last three Market Capitalization figures came in at $1.0 billion (Q2 2026), $888.4 million (Q1 2026), and $1.1 billion (Q4 2025), per Business Quant data.